Pelvic Bioelectronic Medicine: A New FrontierFor decades, neuromodulation has primarily focused on the brain, spinal cord, and vagus nerve, transforming the treatment of numerous neurological and functional disorders. Yet one…
PosStim™: Advancing Toward Direct Pelvic Neuromodulation A Preclinical Milestone in the Development of Targeted Neurostimulation for Pelvic Disorders Introduction Neuromodulation is increasingly recognized as a key therapeutic modality in the…
A CLINICAL PERSPECTIVE ON TARGET SELECTION IN THE TREATMENT OF PELVIC DISORDERS Introduction Neuromodulation has become an established therapeutic option for patients suffering from overactive bladder (OAB) and other pelvic…
Building the Future of Targeted Pelvic Neuromodulation – Bioelectronic Medicine Pelvic medicine is undergoing a fundamental transformation. For decades, the treatment of pelvic disorders has been dominated by organ-based approaches…
Thirty Years of Translational Medical Pioneering NeuroGyn is proud to announce that its founder and CEO, Prof. Marc Possover, has been appointed Chevalier of the Légion d'honneur, France’s highest national…
NeuroGyn is not a device company. NeuroGyn is the owner of a fully patented neuromodulation ecosystem. NeuroGyn has created and owns a vertically integrated, globally protected therapeutic platform that covers,…
Bioelectronic medicine is reshaping the way we understand and treat autonomic and pelvic disorders.Prof. Marc Possover’s presentation “Innovating the Future in Medicine” at the 3th international Congress of Neuropelveology in…
The challenge in "Women's Neuromodulation" NeuroGyn AG introduces PosStim™, a next-generation implantable neurostimulator engineered for Genital Nerve Stimulation (GNS) — a novel, minimally invasive therapy targeting pelvic nerve disorders that…
The challenge in pelvic neurostimulation Pelvic nerve disorders affect vital functions such as bladder/bowel control, sexual performance, and mobility. While neurostimulation can offer a lifeline for patients when conventional treatments…
NeuroGyn Reaches Critical Milestone: PosStim™ Neurostimulator Ready for Clinical Evaluation Zurich, October 2025 – NeuroGyn AG proudly announces a decisive advancement in the development of its proprietary pelvic neurostimulator PosStim™,…